zinquin has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, M; Rink, L; Wellinghausen, N | 1 |
| Campbell, AK; Chin, SF; Davies, S; Errington, RJ; Smith, PJ; Wiltshire, M | 1 |
2 other study(ies) available for zinquin and Lymphoma
| Article | Year |
|---|---|
Zinc inhibits interleukin-1-dependent T cell stimulation.
Topics: Animals; Cells, Cultured; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-1; Interleukin-1 Receptor-Associated Kinases; Lymphocyte Activation; Lymphoma; Mice; Neoplasm Proteins; Protein Kinase Inhibitors; Protein Kinases; Quinolones; T-Lymphocytes; Tosyl Compounds; Tumor Cells, Cultured; Zinc | 1997 |
DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells.
Topics: Apoptosis; Cell Cycle; Chelating Agents; Cytoplasm; DNA Damage; Ethylenediamines; Etoposide; Fluorescent Dyes; Humans; Lymphoma; Nucleic Acid Synthesis Inhibitors; Osmolar Concentration; Quinolones; Subcellular Fractions; Tosyl Compounds; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinc | 2002 |